Filing Flows › Comparisons › RDSC vs BDTB
Radiant Strategies vs Bodhi Tree Biotechnology: RDSC and BDTB compared
Radiant Strategies is the larger company: $15K of revenue in its latest quarter (Q1 FY27) against $10K for Bodhi Tree Biotechnology (Q3 FY26). Radiant Strategies is more profitable, with an operating margin of -47.4% against -232.0%.
Where the money goes: RDSC and BDTB
Radiant Strategies (RDSC) · Q1 FY27
Radiant Strategies, Q1 FY27: revenue $15K (+40% year over year), operating margin -47.4%, net loss $7K, operating cash flow −$10K. The chart follows the revenue to costs, profit and cash.
Bodhi Tree Biotechnology (BDTB) · Q3 FY26
Bodhi Tree Biotechnology, Q3 FY26: revenue $10K, operating margin -232.0%, net loss $23K, operating cash flow −$19K. The chart follows the revenue to costs, profit and cash.
| Radiant Strategies (RDSC) | Bodhi Tree Biotechnology (BDTB) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 FY26 |
| Revenue | $15K | $10K |
| Revenue growth, Y/Y | +40% | — |
| Operating margin | -47.4% | -232.0% |
| Net earnings | −$7K | −$23K |
| Net margin | -47.4% | -231.9% |
| Operating cash flow | −$10K | −$19K |
Questions
Which is bigger, Radiant Strategies or Bodhi Tree Biotechnology?
Radiant Strategies is the larger company: $15K of revenue in its latest quarter (Q1 FY27) against $10K for Bodhi Tree Biotechnology (Q3 FY26).
Is Radiant Strategies or Bodhi Tree Biotechnology growing faster?
Radiant Strategies is more profitable, with an operating margin of -47.4% against -232.0%.
More: Radiant Strategies earnings · how Radiant Strategies makes money · Bodhi Tree Biotechnology earnings · how Bodhi Tree Biotechnology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 25, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.